Management of idiopathic thrombocytopenic purpura

被引：1
作者：
Choudhry V.P. [1 ,2 ]
Kashyap R. [1 ]
Pati H.P. [1 ]
机构：
[1] Department of Hematology, All India Inst. of Medical Sciences, Ansari Nagar, New Delhi
[2] Department of Hematology, All India Inst. of Medical Sciences, Ansari Nagar
来源：
The Indian Journal of Pediatrics | 1998年 / 65卷 / 3期
关键词：
Acute ITP; Chronic ITP; Intracranial hemorrhage; Splenectomy;
D O I：
10.1007/BF02761134
中图分类号：
学科分类号：
摘要：
Idiopathic thrombocytopenic purpura is not an uncommon bleeding disorder with a prevalence of 40-80 per million children per year. Over the last six decades, the subject of ITP has attracted the attention of pediatricians and hematologists. It is one of the subjects which has many controversies because of its unpredictable course heralded by remission relapses, and chronicity with mortality in less than 1% of cases. In the present review only the controversies in the management of acute and chronic ITP have been reviewed as it interests most pediatricians. Management of intracranial hemorrhage (ICH), severe gastrointestinal hemorrhage and menorrhagia continues to still remain a challenge in spite of newer therapies.
引用
收藏
页码：401 / 407
页数：6
相关论文
共 19 条
[1]  
Beardsley D.S., Platelet abnormalities in infancy and childhood, Hematology of Infancy and Childhood 4 Ed., pp. 1561-1604, (1993)
[2]  
Dubansky A.S., Oski F.A., Controversies in the management of acute idiopathic thrombocytopenic purpura. A survey of specialists, Pediatrics, 77, pp. 49-52, (1986)
[3]  
Buchanan G.R., Childhood ITP : How many tests and how much treatment required, J Pediatr, 106, pp. 928-930, (1985)
[4]  
Buchanan G.R., Holtkamp C.A., Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. A randomized clinical trial, Am J Pediatr Hematol Oncol, 6, pp. 355-361, (1984)
[5]  
Sartorius J.A., Steroid treatment of idiopathic thrombocytopenic purpura in childhood. Preliminary results of a randomized cooperative study, Am J Pediatr Hematol Oncol, 6, pp. 165-169, (1984)
[6]  
Von Dem Borne A.E., Vod J.J., Et al., High dose intravenous methylprednisolone or high dose intravenous gammaglobulin for autoimmune thrombocytopenia, Br Med J (Clin Res), 269, (1988)
[7]  
Imbach P., D'Apuzzo V., Hirt A., Et al., High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood, Lancet, 1, pp. 1228-1230, (1981)
[8]  
Imbach P., Berchtold W., Hirt A., Et al., Intravenous IgG versus oral corticosteroids in acute immune thrombocytopenic purpura of childhood, Lancet, 11, pp. 464-468, (1985)
[9]  
Blanchette V.S., Luke B., Andrew M., Et al., A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura, J Pediatr, 123, pp. 989-995, (1993)
[10]  
Albayrak D., Islek I., Kelayee A.G., Et al., Acute immune thrombocytopenic purpura. A comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin, J Pediatr, 125, pp. 1004-1007, (1994)
12